According to a study published in Molecular Cell and reported by EMBL, researchers at EMBL Heidelberg and Ludwig-Maximilians-Universität (LMU) Munich have uncovered how a molecular machine called the MSL complex places a specific chemical mark on a histone protein with high precision. The finding solves a long-standing puzzle in gene regulation and offers new insights into how related enzymes might function in humans, including how disease-associated mutations could disrupt them.

The mark in question is histone acetylation — a tiny chemical tag added to histones, the proteins around which DNA is wrapped to form nucleosomes. These tags can influence gene activity without changing the DNA sequence itself. The researchers focused on the male-specific lethal (MSL) complex, which helps male fruit flies compensate for having only one X chromosome (females have two). To produce the necessary proteins, males must double the activity of genes on their single X chromosome in a process called dosage compensation. A key enzyme in this process, MOF, attaches an acetyl group at a very specific position on a histone, creating a modification known as H4K16 acetylation. This modification makes DNA more accessible to the gene-activating machinery, boosting gene expression.

More than 25 years ago, pioneering work by Peter Becker's group, including research conducted at EMBL, established that H4K16 acetylation is essential for balancing gene activity during dosage compensation. However, how the cell ensures the mark is placed at exactly the right spot remained unknown.

To answer this, the researchers used cryo-electron microscopy (cryo-EM), a technique that allows visualization of molecular structures in extraordinary detail. They captured the MSL complex in action and observed how it positions the chemical tag on the nucleosome. According to EMBL, the team discovered that several parts of the MSL complex must work together to guide the histone into position and place the modification at the correct location.

"Rather than artificially trapping the enzyme, we wanted to observe it during its natural reaction," Sebastian Eustermann, group leader at EMBL Heidelberg, explained in the report. "We were surprised to find that the complex remained bound to the nucleosome even after completing its reaction. This is highly unusual for an enzyme, but it gave us an unprecedented opportunity to understand how it achieves such remarkable precision."

The researchers also found that another chemical modification on histones, one associated with active genes, can accelerate the process. This suggests cells can link gene activity with the same machinery that helps regulate it. Biochemical studies and experiments in fruit fly cells confirmed that this mechanism plays an important role in dosage compensation.

Although the study was conducted in fruit flies, the findings may help explain how gene activity is regulated in humans. The MOF enzyme has a close counterpart in humans, and key features of the mechanism are shared by a wider family of enzymes involved in controlling gene activity. According to EMBL, some of the molecular building blocks that help these enzymes recognize their targets are affected by mutations found in certain diseases. The new findings help explain why these changes may matter: mutations could interfere with the enzyme's ability to recognize and modify the right proteins, potentially disrupting gene regulation.

The study, titled "Molecular mechanism of residue-specific nucleosome acetylation," was published in Molecular Cell on November 19, 2026, and brought together the expertise of Sebastian Eustermann's group at EMBL Heidelberg and Peter Becker's group at the Biomedical Center at LMU Munich.